- Jason Edward Ochs
- May 29, 2026
For over a decade, engineered stone—commonly known as quartz—has been the darling of the home renovation market. Prized for its durability, stain resistance, and sleek aesthetic, it has rapidly overtaken natural marble and granite to become the go-to material for…
- Jason Edward Ochs
- May 20, 2026
It’s a scenario that has become entirely too common. A company suffers a cyberattack, sensitive customer or employee data is stolen, and the public relations nightmare begins. But once the immediate technical fire is put out, a second, often more…
- Jason Edward Ochs
- May 5, 2026
In the high-stakes world of corporate litigation, power is often measured by the size of a legal team or the depth of a company’s war chest. For the average person, standing up to a multi-billion-dollar corporation feels like a fool’s…
- Jason Edward Ochs
- April 16, 2026
For decades, Depo-Provera (the “birth control shot”) has been a go-to for millions of women seeking convenient, long-term contraception. However, recent landmark studies and a major FDA update have brought a serious potential side effect into the spotlight: intracranial meningioma….
- Jason Edward Ochs
- February 3, 2026
When you’re facing a life-altering injury or a complex legal battle, the phrase “personal injury lawyer” can feel a bit hollow. In a world of high-volume firms and “settlement mills,” finding an advocate who truly understands the inside of a…
- Jason Edward Ochs
- January 28, 2026
For years, Dupixent (dupilumab) has been hailed as a breakthrough for those suffering from moderate-to-severe eczema (atopic dermatitis) and asthma. However, a growing number of legal claims and scientific studies have raised concerns about a potential connection between the drug…
- Jason Edward Ochs
- January 22, 2026
For decades, agricultural workers and commercial pesticide applicators have been the backbone of the American food supply. Today, however, many of these same individuals are facing a devastating diagnosis: Parkinson’s Disease. While Parkinson’s is often discussed as a genetic or…
- Jason Edward Ochs
- December 30, 2025
The landscape for GLP-1 receptor agonists—popular medications like Ozempic, Wegovy, and Mounjaro—is shifting rapidly. While these drugs have revolutionized the treatment of Type 2 diabetes and obesity, they are now at the center of significant legal scrutiny. As of December…
- Jason Edward Ochs
- December 9, 2025
PFAS (per- and polyfluoroalkyl substances) are a group of man-made chemicals that have been used in various industrial and consumer products since the 1940s. From non-stick cookware to firefighting foams, their widespread use has led to ubiquitous environmental contamination, with…
- Jason Edward Ochs
- December 9, 2025
Jackson, Wyoming — The Ochs Law Firm has filed a civil complaint in the United States District Court for the District of Wyoming on behalf of David Mecartney against Teton Media Works, Inc. d/b/a Jackson Hole News & Guide. The suit alleges the newspaper published and republished…
